Wolverine Trading, LLC Immunovant, Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$25.1 - $31.61 $87,850 - $110,635	3,500 Added 52.24%	10,200 $269,000
Q1 2024 May 15, 2024	BUY	$30.27 - $43.79 $202,809 - $293,393	6,700 New	6,700 $216,000
Q3 2023 Nov 15, 2023	BUY	$18.55 - $39.96 $617,715 - $1.33 Million	33,300 New	33,300 $1.28 Million
Q3 2021 Nov 12, 2021	SELL	$7.01 - $11.37 $10,515 - $17,055	-1,500 Reduced 8.82%	15,500 $137,000
Q2 2021 Aug 06, 2021	BUY	$9.4 - $16.85 $159,800 - $286,450	17,000 New	17,000 $184,000

220

65.1M

697K

629K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.